Burns in children: Standard and new treatments

The Lancet

Volumn 383, Issue 9923, 2014, Pages 1168-1178

  Jeschke, Marc G ^a,b,c   Herndon, David N ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Canada   (Canada)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; GLUCAGON LIKE PEPTIDE 1; HUMAN GROWTH HORMONE; INSULIN; METFORMIN; OXANDROLONE; PROPRANOLOL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

BODY SURFACE; BURN; CLINICAL TRIAL (TOPIC); CRYSTALLOID; ENDOTRACHEAL INTUBATION; FACIAL TRANSPLANTATION; GOLD STANDARD; HUMAN; HYPERMETABOLISM; INHALATION; INJURY; INTENSIVE CARE UNIT; MORTALITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK ASSESSMENT; SHOCK; STANDARD; STEM CELL TRANSPLANTATION; THICKNESS; UREMIA; WOUND CLOSURE; BURN SHOCK; CHILD CARE; FULL THICKNESS BURN; LUNG BURN; MULTICENTER STUDY (TOPIC); NUTRITIONAL SUPPORT; PARTIAL THICKNESS BURN;

ADOLESCENT; BIOLOGICAL DRESSINGS; BURNS; CHILD; CHILD, PRESCHOOL; FACIAL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; METABOLIC DISEASES; RESUSCITATION; SMOKE INHALATION INJURY; WOUND CLOSURE TECHNIQUES;

EID: 84897073098     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61093-4     Document Type: Review

References (149)

1. WHO. The injury chartbook: a graphical overview of the global burden of injuries. Geneva: World Health Organization, 2002.
2. Herndon DN. Total burn care. 3rd edn. Philadelphia: Saunders Elsevier; 2007.
3. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet 2004; 363: 1895-902.
4. Jeschke MG, Kamolz L, Sjoeberg F, Wolf SE. Handbook of burns, vol 1. Vienna: Springer; 2012.
5. Kraft R, Herndon DN, Al-Mousawi AM, Williams FN, Finnerty CC, Jeschke MG. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet 2012; 379: 1013-21.
6. Greenhalgh DG, Saffle JR, Holmes JH 4th, et al, and the American Burn Association Consensus Conference on Burn Sepsis and Infection Group. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007; 28: 776-90.
7. Jeschke MG, Chinkes DL, Finnerty CC, et al. Pathophysiologic response to severe burn injury. Ann Surg 2008; 248: 387-401.
8. Peck MD. Epidemiology of burns throughout the world. Part I: Distribution and risk factors. Burns 2011; 37: 1087-100.
9. Peck MD. Epidemiology of burns throughout the World. Part II: intentional burns in adults. Burns 2012; 38: 630-37.
10. Williams FN, Herndon DN, Hawkins HK, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care 2009; 13: R183.
11. Roberts G, Lloyd M, Parker M, et al. The Baux score is dead. Long live the Baux score: a 27-year retrospective cohort study of mortality at a regional burns service. J Trauma Acute Care Surg 2012; 72: 251-56.
12. Greenhalgh DG. Burn resuscitation. J Burn Care Res 2007; 28: 555-65.
13. Greenhalgh DG. Burn resuscitation: the results of the ISBI/ABA survey. Burns 2010; 36: 176-82.
14. Kraft R, Herndon DN, Branski LK, Finnerty CC, Leonard KR, Jeschke MG. Optimized fluid management improves outcomes of pediatric burn patients. J Surg Res 2013; 181: 121-28.
15. Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med 2009; 37: 2819-26.
16. Pruitt BA Jr. Protection from excessive resuscitation: "pushing the pendulum back". J Trauma 2000; 49: 567-68.
17. Saffle JI. The phenomenon of "fluid creep" in acute burn resuscitation. J Burn Care Res 2007; 28: 382-95.
18. Klein MB, Hayden D, Elson C, et al. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg 2007; 245: 622-28.
19. Branski LK, Herndon DN, Byrd JF, et al. Transpulmonary thermodilution for hemodynamic measurements in severely burned children. Crit Care 2011; 15: R118.
20. Salinas J, Chung KK, Mann EA, et al. Computerized decision support system improves fluid resuscitation following severe burns: an original study. Crit Care Med 2011; 39: 2031-38.
21. Salinas J, Drew G, Gallagher J, et al. Closed-loop and decision-assist resuscitation of burn patients. J Trauma 2008; 64 (suppl): S321-32.
22. Faraklas I, Lam U, Cochran A, Stoddard G, Saffle J. Colloid normalizes resuscitation ratio in pediatric burns. J Burn Care Res 2011; 32: 91-97.
23. Belba MK, Petrela EY, Belba GP. Comparison of hypertonic vs isotonic fluids during resuscitation of severely burned patients. Am J Emerg Med 2009; 27: 1091-96.
24. Bulger EM, May S, Brasel KJ, et al, and the ROC Investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 2010; 304: 1455-64.
25. Endorf F W, Gamelli RL. Inhalation injury, pulmonary perturbations, and fluid resuscitation. J Burn Care Res 2007; 28: 80-83.
26. Palmieri TL, Warner P, Mlcak RP, et al. Inhalation injury in children: a 10 year experience at Shriners Hospitals for Children. J Burn Care Res 2009; 30: 206-08.
27. Sheridan RL, Hess D. Inhaled nitric oxide in inhalation injury. J Burn Care Res 2009; 30: 162-64.
28. Erdman AR. Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance in the haze. Ann Emerg Med 2007; 49: 814-16.
29. Finnerty CC, Herndon DN, Jeschke MG. Inhalation injury in severely burned children does not augment the systemic inflammatory response. Crit Care 2007; 11: R22.
30. Janzekovic Z. Early surgical treatment of the burned surface. Panminerva Med 1972; 14: 228-32.
31. Desai MH, Herndon DN, Broemeling L, Barrow RE, Nichols RJ Jr, Rutan RL. Early burn wound excision significantly reduces blood loss. Ann Surg 1990; 211: 753-59, discussion 759-62.
32. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 1989; 209: 547-52, discussion 552-53.
33. Herndon DN, Parks DH. Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma 1986; 26: 149-52.
34. Rahmanian-Schwarz A, Beiderwieden A, Willkomm LM, Amr A, Schaller HE, Lotter O. A clinical evaluation of Biobrane(®) and Suprathel(®) in acute burns and reconstructive surgery. Burns 2011; 37: 1343-48.
35. Wood F, Martin L, Lewis D, et al. A prospective randomised clinical pilot study to compare the effectiveness of Biobrane® synthetic wound dressing, with or without autologous cell suspension, to the local standard treatment regimen in paediatric scald injuries. Burns 2012; 38: 830-39.
36. Lesher AP, Curry RH, Evans J, et al. Effectiveness of Biobrane for treatment of partial-thickness burns in children. J Pediatr Surg 2011; 46: 1759-63.
37. Pham C, Greenwood J, Cleland H, Woodruff P, Maddern G. Bioengineered skin substitutes for the management of burns: a systematic review. Burns 2007; 33: 946-57.
38. Barret JP, Dziewulski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane versus 1% silver sulfadiazine in second-degree pediatric burns. Plast Reconstr Surg 2000; 105: 62-65.
39. Branski LK, Herndon DN, Celis MM, Norbury WB, Masters OE, Jeschke MG. Amnion in the treatment of pediatric partial-thickness facial burns. Burns 2008; 34: 393-99.
40. Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-28.
41. Yannas IV, Burke JF, Orgill DP, Skrabut EM. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982; 215: 174-76.
42. Heimbach DM, Warden GD, Luterman A, et al. Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 2003; 24: 42-48.
43. Wainwright DJ, Bury SB. Acellular dermal matrix in the management of the burn patient. Aesthet Surg J 2011; 31 (suppl): 13S-23S.
44. Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns 2006; 32: 395-401.
45. Gravante G, Di Fede MC, Araco A, et al. A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns. Burns 2007; 33: 966-72.
46. Wood FM, Giles N, Stevenson A, Rea S, Fear M. Characterisation of the cell suspension harvested from the dermal epidermal junction using a ReCell® kit. Burns 2012; 38: 44-51.
47. Boyce ST. Skin substitutes from cultured cells and collagen-GAG polymers. Med Biol Eng Comput 1998; 36: 791-800.
48. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD. The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 1999; 20: 453-61.
49. Boyce ST, Rice RK, Lynch KA, et al. Assessment of replication rates of human keratinocytes in engineered skin substitutes grafted to athymic mice. Wound Repair Regen 2012; 20: 544-51.
50. Sriwiriyanont P, Lynch KA, Maier EA, Hahn JM, Supp DM, Boyce ST. Morphogenesis of chimeric hair follicles in engineered skin substitutes with human keratinocytes and murine dermal papilla cells. Exp Dermatol 2012; 21: 783-85.
51. Drago H, Marín GH, Sturla F, et al. The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant Proc 2010; 42: 345-49.
52. Ge L, Sun L, Chen J, et al. The viability change of pigskin in vitro. Burns 2010; 36: 533-38.
53. Branski LK, Gauglitz GG, Herndon DN, Jeschke MG. A review of gene and stem cell therapy in cutaneous wound healing. Burns 2009; 35: 171-80.
54. Wu Y, Zhao RC, Tredget EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 2010; 28: 905-15.
55. Kita K, Gauglitz GG, Phan TT, Herndon DN, Jeschke MG. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev 2010; 19: 491-502.
56. Trojahn Kølle SF, Oliveri RS, Glovinski PV, Elberg JJ, Fischer-Nielsen A, Drzewiecki KT. Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies. J Plast Surg Hand Surg 2012; 46: 59-68.
57. Guenou H, Nissan X, Larcher F, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 2009; 374: 1745-53.
58. Pomahac B, Nowinski D, Diaz-Siso JR, et al. Face transplantation. Curr Probl Surg 2011; 48: 293-357.
59. Pomahac B, Pribaz J, Eriksson E, et al. Three patients with full facial transplantation. N Engl J Med 2012; 366: 715-22.
60. Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: early report. Lancet 2006; 368: 203-09.
61. Petruzzo P, Testelin S, Kanitakis J, et al. First human face transplantation: 5 years outcomes. Transplantation 2012; 93: 236-40.
62. Soni CV, Barker JH, Pushpakumar SB, et al. Psychosocial considerations in facial transplantation. Burns 2010; 36: 959-64.
63. Pushpakumar SB, Barker JH, Soni CV, et al. Clinical considerations in face transplantation. Burns 2010; 36: 951-58.
64. Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One 2011; 6: e21245.
65. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107-24.
66. Coombes EJ, Batstone GF. Urine cortisol levels after burn injury. Burns 1982; 8: 333-37.
67. Goodall M, Stone C, Haynes BW Jr. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 1957; 145: 479-87.
68. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000; 232: 455-65.
69. Jeschke MG, Klein D, Herndon DN. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004; 239: 553-60.
70. Mlcak RP, Jeschke MG, Barrow RE, Herndon DN. The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 2006; 244: 121-30.
71. Norbury WB, Herndon DN. Modulation of the hypermetabolic response after burn injury. In: Herndon DN, ed. Total burn care, 3rd edn. New York: Saunders Elsevier; 2007: 420-33.
72. Przkora R, Barrow RE, Jeschke MG, et al. Body composition changes with time in pediatric burn patients. J Trauma 2006; 60: 968-71.
73. Przkora R, Herndon DN, Suman OE, et al. Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients. Ann Surg 2006; 243: 796-801.
74. Sheridan RL. A great constitutional disturbance. N Engl J Med 2001; 345: 1271-72.
75. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009; 94: 1656-64.
76. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51: 540-44.
77. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med 2002; 30: 2438-42.
78. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery 2008; 144: 629-35.
79. Jeschke MG, Kulp GA, Kraft R, et al. Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med 2010; 182: 351-59.
80. Barret JP, Jeschke MG, Herndon DN. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 2001; 51: 736-39.
81. Barrow RE, Wolfe RR, Dasu MR, Barrow LN, Herndon DN. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann Surg 2006; 243: 115-20.
82. Martini WZ, Irtun O, Chinkes DL, Rasmussen B, Traber DL, Wolfe RR. Alteration of hepatic fatty acid metabolism after burn injury in pigs. JPEN J Parenter Enteral Nutr 2001; 25: 310-16.
83. Morio B, Irtun O, Herndon DN, Wolfe RR. Propranolol decreases splanchnic triacylglycerol storage in burn patients receiving a high-carbohydrate diet. Ann Surg 2002; 236: 218-25.
84. Gore DC, Ferrando A, Barnett J, et al. Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma 2000; 49: 673-77.
85. Wolfe RR, Miller HI, Spitzer JJ. Glucose and lactate kinetics in burn shock. Am J Physiol 1977; 232: E415-18.
86. Jeschke MG, Klein D, Thasler WE, et al. Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol Med 2008; 14: 11-19.
87. Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL. Impact of tight glycemic control in severely burned children. J Trauma 2005; 59: 1148-54.
88. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-89.
89. Barrow RE, Hawkins HK, Aarsland A, et al. Identification of factors contributing to hepatomegaly in severely burned children. Shock 2005; 24: 523-28.
90. Jeschke MG. The hepatic response to thermal injury: is the liver important for postburn outcomes? Mol Med 2009; 15: 337-51.
91. Cree MG, Newcomer BR, Herndon DN, et al. PPAR-alpha agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial. Nutr Metab (Lond) 2007; 4: 9.
92. Cree MG, Newcomer BR, Katsanos CS, et al. Intramuscular and liver triglycerides are increased in the elderly. J Clin Endocrinol Metab 2004; 89: 3864-71.
93. Mochizuki H, Trocki O, Dominioni L, Brackett KA, Joffe SN, Alexander J W. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 1984; 200: 297-310.
94. Williams FN, Jeschke MG, Chinkes DL, et al. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg 2009; 208: 489-502.
95. Saffle JR, Graves C. Nutritional support of the burned patient. In: Herndon DN, ed. Total burn care, 3rd edn. London: Saunders Elsevier; 2007: 398-419.
96. Gore DC, Rutan RL, Hildreth M, Desai MH, Herndon DN. Comparison of resting energy expenditures and caloric intake in children with severe burns. J Burn Care Rehabil 1990; 11: 400-04.
97. Suman OE, Mlcak RP, Chinkes DL, Herndon DN. Resting energy expenditure in severely burned children: analysis of agreement between indirect calorimetry and prediction equations using the Bland-Altman method. Burns 2006; 32: 335-42.
98. Royall D, Fairholm L, Peters WJ, Jeejeebhoy KN, Allard JP. Continuous measurement of energy expenditure in ventilated burn patients: an analysis. Crit Care Med 1994; 22: 399-406.
99. Gore DC, Chinkes D, Sanford A, Hart DW, Wolf SE, Herndon DN. Influence of fever on the hypermetabolic response in burn-injured children. Arch Surg 2003; 138: 169-74.
100. Wischmeyer PE. The glutamine story: where are we now? Curr Opin Crit Care 2006; 12: 142-48.
101. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001; 29: 2075-80.
102. Heyland D, Muscedere J, Wischmeyer PE, et al, and the Canadian Critical Care Trials Group. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368: 1489-97.
103. Gamliel Z, DeBiasse MA, Demling RH. Essential microminerals and their response to burn injury. J Burn Care Rehabil 1996; 17: 264-72.
104. Berger MM. Can oxidative damage be treated nutritionally? Clin Nutr 2005; 24: 172-83.
105. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 2006; 21: 438-49.
106. Berger MM, Baines M, Raffoul W, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr 2007; 85: 1293-300.
107. Berger MM, Binnert C, Chiolero RL, et al. Trace element supplementation after major burns increases burned skin trace element concentrations and modulates local protein metabolism but not whole-body substrate metabolism. Am J Clin Nutr 2007; 85: 1301-06.
108. Berger MM, Eggimann P, Heyland DK, et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials. Crit Care 2006; 10: R153.
109. Berger MM, Shenkin A. Vitamins and trace elements: practical aspects of supplementation. Nutrition 2006; 22: 952-55.
110. Berger MM, Shenkin A. Trace element requirements in critically ill burned patients. J Trace Elem Med Biol 2007; 21 (suppl 1): 44-48.
111. Solomon JR. Early surgical excision and grafting of burns including tangential excision. Prog Pediatr Surg 1981; 14: 133-49.
112. Wilmore DW, Mason AD Jr, Johnson DW, Pruitt BA Jr. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Physiol 1975; 38: 593-97.
113. Suman OE, Spies RJ, Celis MM, Mlcak RP, Herndon DN. Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol 2001; 91: 1168-75.
114. Herndon DN, Hawkins HK, Nguyen TT, Pierre E, Cox R, Barrow RE. Characterization of growth hormone enhanced donor site healing in patients with large cutaneous burns. Ann Surg 1995; 221: 649-56.
115. Jeschke MG, Herndon DN, Wolf SE, et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 1999; 83: 122-29.
116. Jeschke MG, Chrysopoulo MT, Herndon DN, Wolf SE. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res 1999; 85: 171-77.
117. Branski LK, Herndon DN, Barrow RE, et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children. Ann Surg 2009; 250: 514-23.
118. Aili Low JF, Barrow RE, Mittendorfer B, Jeschke MG, Chinkes DL, Herndon DN. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns 2001; 27: 447-52.
119. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-92.
120. Demling R. Growth hormone therapy in critically ill patients. N Engl J Med 1999; 341: 837-39.
121. Ramirez RJ, Wolf SE, Barrow RE, Herndon DN. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg 1998; 228: 439-48.
122. Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999; 229: 713-20.
123. CioffiWG, Gore DC, Rue LW 3rd, et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994; 220: 310-16.
124. Jeschke MG, Barrow RE, Herndon DN. Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children. Ann Surg 2000; 231: 246-52.
125. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001; 233: 556-64.
126. Demling RH, DeSanti L. Oxandrolone induced lean mass gain during recovery from severe burns is maintained after discontinuation of the anabolic steroid. Burns 2003; 29: 793-97.
127. Demling RH, Seigne P. Metabolic management of patients with severe burns. World J Surg 2000; 24: 673-80.
128. Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res 2006; 27: 131-39.
129. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007; 246: 351-60.
130. Porro LJ, Herndon DN, Rodriguez NA, et al. Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy. J Am Coll Surg 2012; 214: 489-502.
131. Przkora R, Herndon DN, Suman OE. The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. Pediatrics 2007; 119: e109-16.
132. Jeschke MG, Norbury WB, Finnerty CC, Branski LK, Herndon DN. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma 2007; 62: 676-81.
133. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001; 345: 1223-29.
134. Brooks NC, Song J, Boehning D, et al. Propranolol improves impaired hepatic phosphatidylinositol 3-kinase/akt signaling after burn injury. Mol Med 2012; 18: 707-11.
135. Herndon DN, Rodriguez NA, Diaz EC, et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Ann Surg 2012; 256: 402-11.
136. Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN. Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg 2010; 252: 521-27.
137. Pierre EJ, Barrow RE, Hawkins HK, et al. Effects of insulin on wound healing. J Trauma 1998; 44: 342-45.
138. Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004; 240: 340-49.
139. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999; 229: 11-18.
140. Finfer S, Liu B, Chittock DR, et al, and the NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367: 1108-18.
141. Moon RJ, Bascombe LA, Holt RI. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes Obes Metab 2007; 9: 143-45.
142. Gore DC, Wolf SE, Herndon DN, Wolfe RR. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 2003; 54: 555-61.
143. Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg 2005; 241: 334-42.
144. Mecott GA, Herndon DN, Kulp GA, et al. The use of exenatide in severely burned pediatric patients. Crit Care 2010; 14: R153.
145. Jeschke MG, Gauglitz GG, Finnerty CC, Kraft R, Mlcak RP, Herndon DN. Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories. Ann Surg 2013; published online April 10. DOI:10.1097/SLA.0b013e31828dfbf1.
146. Finnerty CC, Qian WJ, Kaushal A, et al. Determination of burn patient outcome by large scale quantitative discovery proteomics. Crit Care Med 2013; 41: 1421-34.
147. Finnerty CC, Ju H, Spratt H, et al. Proteomics improves the prediction of burns mortality: results from regression spline modeling. Clin Transl Sci 2012; 5: 243-49.
148. Ryan CM, Schneider JC, Kazis LE, et al. Benchmarks for multidimensional recovery after burn injury in young adults: The development, validation, and testing of the American Burn Association/Shriners Hospitals for Children Young Adult Burn Outcome Questionnaire. J Burn Care Res 2013; 34: e121-e42.
149. Tompkins RG, Liang MH, Lee AF, Kazis LE, and the Multi-Center Benchmarking Study Working Group. The American Burn Association/Shriners Hospitals for Children Burn Outcomes Program: a progress report at 15 years. J Trauma Acute Care Surg 2012; 73 (suppl 2): S173-78.